Mufg Americas Holdings Corp Jazz Pharmaceuticals PLC Transaction History

Mufg Americas Holdings Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	BUY	$126.59 - $161.18 $632 - $805	5 Added 2.2%	232 $31,000
Q3 2022 Oct 31, 2022	BUY	$126.59 - $161.18 $632 - $805	5 Added 2.2%	232 $31,000
Q4 2021 Dec 01, 2022	SELL	$119.87 - $145.67 $4,674 - $5,681	-39 Reduced 14.66%	227 $29,000
Q4 2021 Feb 09, 2022	SELL	$119.87 - $145.67 $4,674 - $5,681	-39 Reduced 14.66%	227 $29,000
Q3 2021 Dec 01, 2022	BUY	$128.64 - $184.79 $5,016 - $7,206	39 Added 17.18%	266 $35,000
Q3 2021 Nov 05, 2021	BUY	$128.64 - $184.79 $5,016 - $7,206	39 Added 17.18%	266 $35,000
Q2 2020 Dec 01, 2022	SELL	$95.68 - $121.88 $478 - $609	-5 Reduced 2.16%	227 $25,000
Q3 2019 Nov 06, 2019	BUY	$125.18 - $143.24 $28,415 - $32,515	227 New	227 $29,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.